Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-4.64%)
Close on Nov 18, 2026Market cap $1.53MP/E –Yield –
Vivos Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Vivos Therapeutics's price to book ratio was 5.3× on Jan 30, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 0.9× to 323.8×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 5.3× | −1.3 |
| 2025 | Dec 31, 2025 | 6.6× | +4.0 |
| 2024 | Dec 31, 2024 | 2.7× | −321.1 |
| 2023 | Dec 29, 2023 | 323.8× | +322.8 |
| 2022 | Dec 30, 2022 | 0.9× | −0.7 |
| 2021 | Dec 31, 2021 | 1.6× | – |
See a number that looks wrong?